These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8422741)

  • 41. Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjects.
    Peeters PA; Van Lier JJ; Van De Merbel N; Oosterhuis B; Wieling J; Jonkman JH; Klessing K; Biber A
    Eur J Drug Metab Pharmacokinet; 1998; 23(1):45-53. PubMed ID: 9625272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacokinetics of the enantiomers of atenolol.
    Boyd RA; Chin SK; Don-Pedro O; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Apr; 45(4):403-10. PubMed ID: 2702798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1.
    Bogaards JJ; Venekamp JC; van Bladeren PJ
    Chem Res Toxicol; 1997 Mar; 10(3):310-7. PubMed ID: 9084911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of sotalol enantiomers in humans.
    Carr RA; Foster RT; Lewanczuk RZ; Hamilton PG
    J Clin Pharmacol; 1992 Dec; 32(12):1105-9. PubMed ID: 1487548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression.
    Fleishaker JC
    Clin Pharmacokinet; 2000 Dec; 39(6):413-27. PubMed ID: 11192474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.
    Chen TL; Vogelsang GB; Petty BG; Brundrett RB; Noe DA; Santos GW; Colvin OM
    Drug Metab Dispos; 1989; 17(4):402-5. PubMed ID: 2571480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypnotic (barbiturate, non-barbiturate)].
    Fukai Y; Ohta S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():364-7. PubMed ID: 15658339
    [No Abstract]   [Full Text] [Related]  

  • 48. [Practical analysis of toxic substances useful for clinical toxicology--3--Bromovalerylurea].
    Kudo K; Iwasaki Y; Namera A; Yashiki M
    Chudoku Kenkyu; 2002 Jul; 15(3):301-5. PubMed ID: 12415874
    [No Abstract]   [Full Text] [Related]  

  • 49. Stereoselectivity and regioselectivity of purified human glutathione transferases pi, alpha-epsilon, and mu with alkene and polycyclic arene oxide substrates.
    Dostal LA; Guthenberg C; Mannervik B; Bend JR
    Drug Metab Dispos; 1988; 16(3):420-4. PubMed ID: 2900734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and metabolism of bisoprolol enantiomers in humans.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1998 Mar; 87(3):289-94. PubMed ID: 9523980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic study of cicletanine in healthy volunteers.
    Pruñonosa J; Peraire C; Torrent J; Obach R
    Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):265-70. PubMed ID: 1526688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereoselectivity of the glutathione S-transferase catalyzed conjugation of aralkyl halides.
    Mangold JB; Abdel-Monem MM
    Biochem Biophys Res Commun; 1980 Sep; 96(1):333-40. PubMed ID: 7437037
    [No Abstract]   [Full Text] [Related]  

  • 53. Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers.
    Geisslinger G; Lötsch J; Menzel S; Kobal G; Brune K
    Br J Clin Pharmacol; 1994 Apr; 37(4):392-4. PubMed ID: 8018462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate.
    Geisslinger G; Menzel S; Wissel K; Brune K
    Br J Clin Pharmacol; 1995 Jul; 40(1):73-5. PubMed ID: 8527271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease.
    van der Geest R; van Laar T; Kruger PP; Gubbens-Stibbe JM; Boddé HE; Roos RA; Danhof M
    Clin Neuropharmacol; 1998; 21(3):159-68. PubMed ID: 9617507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
    Kharasch ED; Mitchell D; Coles R
    J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of the individual enantiomers of cis-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzamide monohydrochloride (U-54494A) in the dog.
    Zhong WZ; Williams MG; Schuette MR; Vandegiessen TL; Jones BW
    Enantiomer; 1996; 1(2):89-96. PubMed ID: 9676281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers.
    Avgerinos A; Hutt AJ
    Chirality; 1990; 2(4):249-56. PubMed ID: 2083147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of prenylamine racemate and enantiomers in man.
    Paar WD; Brockmeier D; Hirzebruch M; Schmidt EK; von Unruh GE; Dengler HJ
    Arzneimittelforschung; 1990 Jun; 40(6):657-61. PubMed ID: 2397000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.